Genmab ★ 0Sign in to vote

Genmab is a biotechnology company focused on antibody-based medicines for cancer and other serious diseases. Its research centers on antibody science and proprietary technology platforms used to develop therapeutic candidates, including both internal and partnered programs. The company works with biotechnology and pharmaceutical partners and maintains a pipeline of investigational medicines at different stages of development. Genmab publishes information about its science, approved medicines, partnerships, and clinical pipeline on its official site. Investigational programs are not established treatments; current prescribing and clinical information should be consulted for approved products.